Naomi Hunder

Insider Reports History

Entity
Individual
Location
C/O Silverback Therapeutics, Inc., 500 Fairview Avenue N, Suite 600, Seattle, WA
Signature
/s/ Jeffrey C. Pepe, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Naomi Hunder:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Silverback Therapeutics, Inc. Chief Medical Officer Common Stock 54.4K $206K $3.78 May 2, 2022 Direct
Silverback Therapeutics, Inc. Chief Medical Officer Stock Option (right to buy) 86.4K May 2, 2022 Direct

Insider Reports Filed by Naomi Hunder

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SPRY Silverback Therapeutics, Inc. May 2, 2022 2 $0 4 May 4, 2022 Chief Medical Officer
SPRY Silverback Therapeutics, Inc. Feb 1, 2022 3 $0 4 Feb 2, 2022 Chief Medical Officer